College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
College of Kinesiology, University of Saskatchewan, Saskatoon, Canada.
Adv Nutr. 2022 Mar;13(2):424-438. doi: 10.1093/advances/nmab128. Epub 2023 Feb 10.
The recent coronavirus disease 2019 (COVID-19) pandemic has warranted the need to investigate potential therapies or prophylaxis against this infectious respiratory disease. There is emerging evidence about the potential role of nutrients on COVID-19 in addition to using medications such as hydroxychloroquine and azithromycin. This scoping review aims to explore the literature evaluating the effect of immunomodulatory nutrients on the outcomes including hospitalization, intensive care unit admission, oxygen requirement, and mortality in COVID-19 patients. A literature search of databases including Medline, EMBASE, CINAHL, Web of Science, Cochrane, Scopus, and PubMed, as well as hand-searching in Google Scholar (up to 10 February 2021) was conducted. All human studies with different study designs and without limitation on publication year were included except for non-English-language and review articles. Overall, out of 4412 studies, 19 met our inclusion criteria. Four studies examined the impact of supplementation with vitamin C, 4 studies - zinc, 8 studies - vitamin D, and 3 studies investigated the combination of 2 (zinc and vitamin C) or 3 (vitamin D, vitamin B-12, and magnesium) nutrients. Although limited data exist, available evidence demonstrated that supplementation with immune-supportive micronutrients such as vitamins D and C and zinc may modulate immunity and alleviate the severity and risk of infection. The effectiveness of vitamin C, vitamin D, and zinc on COVID-19 was different based on baseline nutrient status, the duration and dosage of nutrient therapy, time of administration, and severity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease. This review indicated that supplementation with high-dose vitamin C, vitamin D, and zinc may alleviate the complications caused by COVID-19, including inflammatory markers, oxygen therapy, length of hospitalization, and mortality; however, studies were mixed regarding these effects. Further randomized clinical trials are necessary to identify the most effective nutrients and the safe dosage to combat SARS-CoV-2.
最近的 2019 年冠状病毒病(COVID-19)大流行需要研究针对这种传染性呼吸道疾病的潜在治疗方法或预防措施。除了使用羟氯喹和阿奇霉素等药物外,还有越来越多的证据表明营养物质在 COVID-19 中的潜在作用。本范围综述旨在探讨评估免疫调节营养素对 COVID-19 患者住院、入住重症监护病房、氧气需求和死亡率等结局影响的文献。对包括 Medline、EMBASE、CINAHL、Web of Science、Cochrane、Scopus 和 PubMed 在内的数据库以及 Google Scholar(截至 2021 年 2 月 10 日)的手工搜索进行了文献检索。纳入了不同研究设计且无发表年份限制的所有人类研究,非英语语言和综述文章除外。总体而言,在 4412 项研究中,有 19 项符合我们的纳入标准。四项研究检查了补充维生素 C 的影响,四项研究 - 锌,八项研究 - 维生素 D,三项研究调查了两种(锌和维生素 C)或三种(维生素 D、维生素 B-12 和镁)营养素的组合。尽管现有数据有限,但现有证据表明,补充免疫支持性微量营养素,如维生素 D 和 C 以及锌,可能调节免疫并减轻感染的严重程度和风险。维生素 C、维生素 D 和锌对 COVID-19 的有效性取决于基线营养状况、营养素治疗的持续时间和剂量、给药时间和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疾病的严重程度。本综述表明,高剂量维生素 C、维生素 D 和锌的补充可能缓解 COVID-19 引起的并发症,包括炎症标志物、氧疗、住院时间和死亡率;然而,这些影响的研究结果不一致。需要进一步的随机临床试验来确定最有效的营养素和安全剂量来对抗 SARS-CoV-2。